Paper Details
- Home
- Paper Details
A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS).
Author: BoyceRichard D, Gómez-LumbrerasAinhoa, HornJohn, MaloneDaniel C, TanMalinda S, Villa-ZapataLorenzo
Original Abstract of the Article :
INTRODUCTION: Tizanidine is primarily metabolized via cytochrome P450 (CYP) 1A2 and therefore medications that inhibit the enzyme will affect the clearance of tizanidine, leading to increased plasma concentrations of tizanidine and potentially serious adverse events. OBJECTIVES: Our aim was to stud...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1007/s40264-022-01200-4
データ提供:米国国立医学図書館(NLM)
Tizanidine and CYP1A2 Inhibitors: A Potential for Dangerous Drug Interactions
This study analyzed data from the FDA Adverse Event Reporting System (FAERS) to investigate the potential for adverse events associated with the combination of tizanidine, a muscle relaxant, and CYP1A2 inhibitors, drugs that can interfere with the metabolism of tizanidine. The researchers found a significant association between tizanidine and CYP1A2 inhibitors, particularly ciprofloxacin and fluvoxamine, and adverse events such as hypotension, bradycardia, syncope, shock, cardiorespiratory arrest, and falls. These findings suggest that concurrent use of tizanidine with CYP1A2 inhibitors could lead to serious health consequences.
Hidden Dangers: Understanding Drug Interactions
This study emphasizes the importance of understanding drug interactions, especially when combining medications that can influence each other's metabolism. The researchers demonstrated a significant association between tizanidine and CYP1A2 inhibitors, highlighting the potential for serious adverse events. This knowledge is crucial for healthcare providers to make informed decisions about medication regimens and minimize the risk of adverse drug reactions.
Navigating Drug Interactions: A Collaborative Approach
The study underscores the importance of communication between patients and healthcare providers regarding their medications. Patients should inform their physicians about all medications they are taking, including over-the-counter medications and supplements, to prevent potential drug interactions. By working collaboratively, patients and healthcare providers can ensure that medication regimens are safe and effective.
Dr. Camel's Conclusion
This study serves as a reminder that the desert of medications can be vast and complex. It's essential to be aware of potential interactions between drugs, especially those that influence each other's metabolism. By understanding these interactions and communicating effectively with healthcare providers, we can navigate the desert of medication safely and effectively, avoiding potential pitfalls and ensuring optimal health outcomes.
Date :
- Date Completed 2022-08-10
- Date Revised 2022-12-27
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.